These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 17939404)

  • 21. AZT and emodin exhibit synergistic growth-inhibitory effects on K562/ADM cells by inducing S phase cell cycle arrest and suppressing MDR1 mRNA/p-gp protein expression.
    Chen P; Liu Y; Sun Y; Chen C; Qi Y; Zhang Y
    Pharm Biol; 2013 Dec; 51(12):1586-91. PubMed ID: 24004004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Reversal of leukemia multidrug resistance by sequence-specific short hairpin RNA].
    Du WT; Liu B; Gu DS; Han ZB; Liu PX; Xu J; Liang L; Zhao HF; Lu SH; Yang RC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):563-7. PubMed ID: 19549364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of arsenic trioxide (As2O3) combined with BSO on K562/ADM cell and its mechanisms].
    Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):438-43. PubMed ID: 18072624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of mdr1-mediated multidrug resistance in human leukemia cells by a new spin-labeled derivative of podophyllotoxin.
    Qi SN; Song LJ; Chen Y; Jing YX
    Pharmazie; 2010 Feb; 65(2):117-21. PubMed ID: 20225656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of CD44 gene silence on multi-drug resistance reversal and biologic activity in K562/A02 cells].
    Liu YP; Liu CF; Ma DX; Lu F; Zhang JJ; Kong HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):335-9. PubMed ID: 20416163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Suppression of MDR1 expression and restoration of sensitivity to chemotherapy in multidrug-resistant hepatocellular carcinoma cell line Bel7402/5-Fu by RNA interference].
    Ren YY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Dec; 31(6):872-6. PubMed ID: 17213586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The study on reversing mechanism of multidrug resistance of K562/A02 cell line by curcumin and erythromycin].
    Chang HY; Pan KL; Ma FC; Jiao XY; Zhu HF; Liu JH; Huang Y; Cao YH
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):254-8. PubMed ID: 16875558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
    Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDR reversal activity of bromotetrandrine in vitro and in vivo.
    Cheng J; Wang JQ; Chen BA; Gao F; Xu WL; Shen HL; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Song HH; Bao W; Sun Q; Dai YY; Sun XC; Cheng HY; Deng YX; Li GH; Chen NN; Liu LJ; Wang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1183-91. PubMed ID: 19840447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reversing multidrug resistance in breast cancer cell line MCF-7/ADR by small interfering RNA].
    Li CB; Zhang F; Shi YR; Wei XY; Yang Y; Niu RF
    Ai Zheng; 2004 Dec; 23(12):1605-10. PubMed ID: 15601546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study on RNA interference reversing the multidrug resistance of leukemia cell].
    Gu L; Liu T; Gong YP; Xi YM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):45-8. PubMed ID: 17294725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Enhancive effect of HMGB1 gene silence on adriamycin-induced apoptosis in K562/A02 drug resistance leukemia cells].
    Xie M; Kang R; Yu Y; Zhu S; He YL; Xu WQ; Tang DL; Cao LZ
    Zhonghua Xue Ye Xue Za Zhi; 2008 Aug; 29(8):549-52. PubMed ID: 19112920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Arsenic trioxide inhibits P-glycoprotein expression in multidrug-resistant human leukemia K562/ADM cell line that overexpresses mdr-1 gene and enhances their chemotherapeutic sensitivity].
    Wei HL; Yao XJ; Li YN; Wang P; Zhao HS; Bai DC; Peng X; Ma LF
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jan; 24(1):28-31. PubMed ID: 12679007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experimental study of adenovirus-mediated p53 gene on the reversal of multidrug resistance in breast cancer].
    He SZ; Qi XD; Zhang XM; Wang Y
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2935-7. PubMed ID: 18261311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Establishment of a drug resistant leukemia cell line caused by mdr1 gene].
    Gu L; Liu T; Gong YP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):475-6, 509. PubMed ID: 16078564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
    Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
    Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversing multidrug-resistant by RNA interference through silencing MDR1 gene in human hepatocellular carcinoma cells subline Bel-7402/ADM.
    Sheng L; Xiong M; Li C; Meng X
    Pathol Oncol Res; 2014 Jul; 20(3):541-8. PubMed ID: 24327315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tegillarca granosa extract Haishengsu (HSS) suppresses expression of mdr1, BCR/ABL and sorcin in drug-resistant K562/ADM tumors in mice.
    Li GY; Liu JZ; Zhang B; Yang M; Chen SG; Hou M; Wang LX
    Adv Med Sci; 2013; 58(1):112-7. PubMed ID: 23729583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulating multidrug resistance gene in leukaemia cells by short interfering RNA.
    Lim MN; Lau NS; Chang KM; Leong CF; Zakaria Z
    Singapore Med J; 2007 Oct; 48(10):932-8. PubMed ID: 17909680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Reversion Mechanism Study of PESV to Multidrug Resistance at Leukemia Stem Cell Level].
    Yang XD; Shi ZX; Yan LX; Liu BS; Chen HY; Yan TG; Zhang WF; Yang X; Qin HR; Liu C; Ji HX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jul; 36(7):867-874. PubMed ID: 30634217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.